0001144204-16-077533.txt : 20160128 0001144204-16-077533.hdr.sgml : 20160128 20160128144518 ACCESSION NUMBER: 0001144204-16-077533 CONFORMED SUBMISSION TYPE: 424B2 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20160128 DATE AS OF CHANGE: 20160128 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HSBC USA INC /MD/ CENTRAL INDEX KEY: 0000083246 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] IRS NUMBER: 132764867 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B2 SEC ACT: 1933 Act SEC FILE NUMBER: 333-202524 FILM NUMBER: 161368125 BUSINESS ADDRESS: STREET 1: 452 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 2125253735 MAIL ADDRESS: STREET 1: 452 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10018 424B2 1 v429884_424b2.htm PRICING SUPPLEMENT

Title of Each Class of Securities Offered		Maximum Aggregate Offering Price		Amount of Registration Fee⁽¹⁾
Debt Securities		$4,212,000		$424.15

⁽¹⁾ Calculated in accordance with Rule 457(r) of the Securities Act of 1933, as amended.

Filed Pursuant to Rule 424(b)(2)

Registration No. 333-202524

January 26, 2016

PRICING SUPPLEMENT

(To Prospectus dated March 5, 2015,

Prospectus Supplement dated March 5, 2015 and

Equity Index Underlying Supplement dated March 5, 2015)

HSBC USA Inc.

Buffered Uncapped Market

Participation Securities^TM

$4,212,000 Buffered Uncapped Market Participation Securities linked to the S&P 500^® Index

Maturity of 5 years

1.00x uncapped exposure to any positive return of the reference asset

Protection from the first 20% of any losses of the reference asset

All payments on the securities are subject to the credit risk of HSBC USA Inc.

The Buffered Uncapped Market Participation Securities (each a “security” and collectively the “securities") offered hereunder will not be listed on any U.S. securities exchange or automated quotation system. The securities will not bear interest.

Neither the U.S. Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of the securities or passed upon the accuracy or the adequacy of this document, the accompanying prospectus, prospectus supplement or Equity Index Underlying Supplement. Any representation to the contrary is a criminal offense. We have appointed HSBC Securities (USA) Inc., an affiliate of ours, as the agent for the sale of the securities. HSBC Securities (USA) Inc. will purchase the securities from us for distribution to other registered broker-dealers or will offer the securities directly to investors. In addition, HSBC Securities (USA) Inc. or another of its affiliates or agents may use this pricing supplement in market-making transactions in any securities after their initial sale. Unless we or our agent informs you otherwise in the confirmation of sale, this pricing supplement is being used in a market-making transaction. See “Supplemental Plan of Distribution (Conflicts of Interest)” on page PS-9 of this pricing supplement.

Investment in the securities involves certain risks. You should refer to “Risk Factors” beginning on page PS-5 of this document, page S-1 of the accompanying prospectus supplement and page S-2 of the accompanying Equity Index Underlying Supplement.

The Estimated Initial Value of the securities on the Pricing Date is $934.00 per security, which is less than the price to public. The market value of the securities at any time will reflect many factors and cannot be predicted with accuracy. See “Estimated Initial Value” on page PS-2 and “Risk Factors” beginning on page PS-5 of this document for additional information.

	Price to Public	Underwriting Discount¹	Proceeds to Issuer
Per security	$1,000.00	$37.50	$962.50
Total	$4,212,000.00	$157,950.00	$4,054,050.00

¹ HSBC USA Inc. or one of our affiliates may pay varying underwriting discounts of up to 3.75% and referral fees of up to 1.60% per $1,000 Principal Amount in connection with the distribution of the securities to other registered broker-dealers. In no case will the sum of the underwriting discounts and referral fees exceed 3.75% per $1,000 Principal Amount. See “Supplemental Plan of Distribution (Conflicts of Interest)” on page PS-9 of this pricing supplement.

The securities:

Are Not FDIC Insured

Are Not Bank Guaranteed

May Lose Value

HSBC USA Inc.

Buffered Uncapped Market Participation Securities

Linked to the S&P 500^® Index

This pricing supplement relates to a single offering of Buffered Uncapped Market Participation Securities. The securities will have the terms described in this pricing supplement and the accompanying prospectus, prospectus supplement and Equity Index Underlying Supplement. If the terms of the securities offered hereby are inconsistent with those described in the accompanying prospectus, prospectus supplement, or Equity Index Underlying Supplement, the terms described in this pricing supplement shall control. You should be willing to forgo interest and dividend payments during the term of the securities and, if the Reference Return is less than the Buffer Level, lose up to 80% of your principal.

This pricing supplement relates to an offering of securities linked to the performance of the S&P 500^® Index (the “Reference Asset”). The purchaser of a security will acquire a senior unsecured debt security of HSBC USA Inc. linked to the Reference Asset as described below. The following key terms relate to the offering of securities:

Issuer:		HSBC USA Inc.
Principal Amount:		$1,000 per security
Reference Asset:		The S&P 500^® Index (“SPX”)
Trade Date:		January 26, 2016
Pricing Date:		January 26, 2016
Original Issue Date:		January 29, 2016
Final Valuation Date:		January 26, 2021, subject to adjustment as described under “Additional Terms of the Notes—Valuation Dates” in the accompanying Equity Index Underlying Supplement.
Maturity Date:		January 29, 2021. The Maturity Date is subject to adjustment as described under “Additional Terms of the Notes—Coupon Payment Dates, Call Payment Dates and Maturity Date” in the accompanying Equity Index Underlying Supplement.
Upside Participation Rate:		100% (1.00x)
Payment at Maturity:		On the Maturity Date, for each security, we will pay you the Final Settlement Value.
Reference Return:		The quotient, expressed as a percentage, calculated as follows:
		Final Level – Initial Level Initial Level
Final Settlement Value:		*If the Reference Return is greater than zero,* you will receive a cash payment on the Maturity Date, per $1,000 Principal Amount, calculated as follows: $1,000 + ($1,000 × Reference Return × Upside Participation Rate). *If the Reference Return is less than or equal to zero but greater than or equal to the Buffer Level,* you will receive $1,000 per $1,000 Principal Amount (zero return). *If the Reference Return is less than the Buffer Level,* you will receive a cash payment on the Maturity Date, per $1,000 Principal Amount, calculated as follows: $1,000 + [$1,000 × (Reference Return + 20%)]. Under these circumstances, you will lose 1% of the Principal Amount of your securities for each percentage point that the Reference Return is below the Buffer Level. For example, if the Reference Return is -30%, you will suffer a 10% loss and receive 90% of the Principal Amount, subject to the credit risk of HSBC. If the Reference Return is less than the Buffer Level, you may lose up to 80% of your investment.
Buffer Level:		-20%
Initial Level:		1,903.63, which was the Official Closing Level of the Reference Asset on the Pricing Date.
Final Level:		The Official Closing Level of the Reference Asset on the Final Valuation Date.
Official Closing Level:		The closing level of the Reference Asset on any scheduled trading day as determined by the Calculation Agent based upon the level displayed on the Bloomberg Professional^® service page “SPX <INDEX>”, or on any successor page on the Bloomberg Professional^® service or any successor service, as applicable.
Form of Securities:		Book-Entry
Listing:		The securities will not be listed on any U.S. securities exchange or quotation system.
CUSIP/ISIN:		40433UFQ4/US40433UFQ40
Estimated Initial Value:		The Estimated Initial Value of the securities is less than the price you pay to purchase the securities. The Estimated Initial Value does not represent a minimum price at which we or any of our affiliates would be willing to purchase your securities in the secondary market, if any, at any time. See “Risk Factors — The Estimated Initial Value of the securities, which was determined by us on the Pricing Date, is less than the price to public and may differ from the market value of the securities in the secondary market, if any.”

PS-2

GENERAL

This pricing supplement relates to an offering of securities linked to the Reference Asset. The purchaser of a security will acquire a senior unsecured debt security of HSBC USA Inc. Although the offering of securities relates to the Reference Asset, you should not construe that fact as a recommendation as to the merits of acquiring an investment linked to the Reference Asset or any component security included in the Reference Asset or as to the suitability of an investment in the securities.

You should read this document together with the prospectus dated March 5, 2015, the prospectus supplement dated March 5, 2015 and the Equity Index Underlying Supplement dated March 5, 2015. If the terms of the securities offered hereby are inconsistent with those described in the accompanying prospectus, prospectus supplement, or Equity Index Underlying Supplement, the terms described in this pricing supplement shall control. You should carefully consider, among other things, the matters set forth in “Risk Factors” beginning on page PS-5 of this pricing supplement, page S-1 of the prospectus supplement and page S-2 of the Equity Index Underlying Supplement, as the securities involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisors before you invest in the securities. As used herein, references to the “Issuer”, “HSBC”, “we”, “us” and “our” are to HSBC USA Inc.

HSBC has filed a registration statement (including a prospectus, prospectus supplement and Equity Index Underlying Supplement) with the SEC for the offering to which this pricing supplement relates. Before you invest, you should read the prospectus, prospectus supplement and Equity Index Underlying Supplement in that registration statement and other documents HSBC has filed with the SEC for more complete information about HSBC and this offering. You may get these documents for free by visiting EDGAR on the SEC’s web site at www.sec.gov. Alternatively, HSBC Securities (USA) Inc. or any dealer participating in this offering will arrange to send you the prospectus, prospectus supplement and Equity Index Underlying Supplement if you request them by calling toll-free 1-866-811-8049.

You may also obtain:

The Equity Index Underlying Supplement at: http://www.sec.gov/Archives/edgar/data/83246/000114420415014327/v403626_424b2.htm

The prospectus supplement at: http://www.sec.gov/Archives/edgar/data/83246/000114420415014311/v403645_424b2.htm

The prospectus at: http://www.sec.gov/Archives/edgar/data/83246/000119312515078931/d884345d424b3.htm

PAYMENT AT MATURITY

On the Maturity Date, for each security you hold, we will pay you the Final Settlement Value, which is an amount in cash, as described below:

If the Reference Return is greater than zero, you will receive a cash payment on the Maturity Date, per $1,000 Principal Amount, calculated as follows:

$1,000 + ($1,000 × Reference Return × Upside Participation Rate).

If the Reference Return is less than or equal to zero but greater than or equal to the Buffer Level, you will receive $1,000 per $1,000 Principal Amount (zero return).

If the Reference Return is less than the Buffer Level, you will receive a cash payment on the Maturity Date, per $1,000 Principal Amount, calculated as follows:

$1,000 + [$1,000 × (Reference Return + 20%)].

Under these circumstances, you will lose 1% of the Principal Amount of your securities for each percentage point that the Reference Return is below the Buffer Level. For example, if the Reference Return is -30%, you will suffer a 10% loss and receive 90% of the Principal Amount, subject to the credit risk of HSBC. You should be aware that if the Reference Return is less than the Buffer Level, you may lose up to 80% of your investment.

PS-3

Interest

The securities will not pay interest.

Calculation Agent

We or one of our affiliates will act as calculation agent with respect to the securities.

Reference Sponsor

S&P Dow Jones Indices LLC, a part of McGraw-Hill Financial, is the reference sponsor.

INVESTOR SUITABILITY

The securities may be suitable for you if:

You seek an investment with a return linked to the potential positive performance of the Reference Asset and you believe the level of the Reference Asset will increase over the term of the securities.

You are willing to make an investment that is exposed to the negative Reference Return on a 1-to-1 basis for each percentage point that the Reference Return is below the Buffer Level of -20%.

You are willing to forgo dividends or other distributions paid to holders of the stocks comprising the Reference Asset.

You are willing to accept the risk and return profile of the securities versus a conventional debt security with a comparable maturity issued by HSBC or another issuer with a similar credit rating.

You do not seek current income from your investment.

You do not seek an investment for which there is an active secondary market.

You are willing to hold the securities to maturity.

You are comfortable with the creditworthiness of HSBC, as Issuer of the securities.

The securities may not be suitable for you if:

You believe the Reference Return will be negative or that the Reference Return will not be sufficiently positive to provide you with your desired return.

You are unwilling to make an investment that is exposed to the negative Reference Return on a 1-to-1 basis for each percentage point that the Reference Return is below the Buffer Level of -20%.

You seek an investment that provides full return of principal.

You prefer the lower risk, and therefore accept the potentially lower returns, of conventional debt securities with comparable maturities issued by HSBC or another issuer with a similar credit rating.

You prefer to receive the dividends or other distributions paid on the stocks comprising the Reference Asset.

You seek current income from your investment.

You seek an investment for which there will be an active secondary market.

You are unable or unwilling to hold the securities to maturity.

You are not willing or are unable to assume the credit risk associated with HSBC, as Issuer of the securities.

PS-4

RISK FACTORS

We urge you to read the section “Risk Factors” beginning on page S-1 of the accompanying prospectus supplement and page S-2 of the accompanying Equity Index Underlying Supplement. Investing in the securities is not equivalent to investing directly in any of the stocks comprising the Reference Asset. You should understand the risks of investing in the securities and should reach an investment decision only after careful consideration, with your advisors, of the suitability of the securities in light of your particular financial circumstances and the information set forth in this pricing supplement and the accompanying prospectus, prospectus supplement and Equity Index Underlying Supplement.

In addition to the risks discussed below, you should review “Risk Factors” in the accompanying prospectus supplement and Equity Index Underlying Supplement including the explanation of risks relating to the securities described in the following sections:

“— Risks Relating to All Note Issuances” in the prospectus supplement; and

“— General Risks Related to Indices” in the Equity Index Underlying Supplement.

You will be subject to significant risks not associated with conventional fixed-rate or floating-rate debt securities.

Your investment in the securities may result in a loss.

You will be exposed to the decline in the Final Level from the Initial Level beyond the Buffer Level of -20%. Accordingly, if the Reference Return is less than the Buffer Level of -20%, your Payment at Maturity will be less than the Principal Amount of your securities. You may lose up to 80% of your investment at maturity if the Reference Return is less than the Buffer Level.

The amount payable on the securities is not linked to the level of the Reference Asset at any time other than on the Final Valuation Date.

The Final Level will be based on the Official Closing Level of the Reference Asset on the Final Valuation Date, subject to postponement for non-trading days and certain market disruption events. Even if the level of the Reference Asset appreciates during the term of the securities other than on the Final Valuation Date but then decreases on the Final Valuation Date to a level that is less than the Initial Level, the Payment at Maturity may be less, and may be significantly less, than it would have been had the Payment at Maturity been linked to the level of the Reference Asset prior to such decrease. Although the actual level of the Reference Asset on the Maturity Date or at other times during the term of the securities may be higher than the Final Level, the Payment at Maturity will be based solely on the Official Closing Level of the Reference Asset on the Final Valuation Date.

Credit risk of HSBC USA Inc.

The securities are senior unsecured debt obligations of the Issuer, HSBC, and are not, either directly or indirectly, an obligation of any third party. As further described in the accompanying prospectus supplement and prospectus, the securities will rank on par with all of the other unsecured and unsubordinated debt obligations of HSBC, except such obligations as may be preferred by operation of law. Any payment to be made on the securities, including any return of principal at maturity, depends on the ability of HSBC to satisfy its obligations as they come due. As a result, the actual and perceived creditworthiness of HSBC may affect the market value of the securities and, in the event HSBC were to default on its obligations, you may not receive the amounts owed to you under the terms of the securities.

The securities will not bear interest.

As a holder of the securities, you will not receive interest payments.

Changes that affect the Reference Asset will affect the market value of the securities and the amount you will receive at maturity.

The policies of the reference sponsor concerning additions, deletions and substitutions of the constituents comprising the Reference Asset and the manner in which the reference sponsor takes account of certain changes affecting those constituents may affect the level of the Reference Asset. The policies of the reference sponsor with respect to the calculation of the Reference Asset could also affect the level of the Reference Asset. The reference sponsor may discontinue or suspend calculation or dissemination of the Reference Asset. Any such actions could affect the value of the securities and the return on the securities.

The securities are not insured or guaranteed by any governmental agency of the United States or any other jurisdiction.

The securities are not deposit liabilities or other obligations of a bank and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency or program of the United States or any other jurisdiction. An investment in the securities is subject to the credit risk of HSBC, and in the event that HSBC is unable to pay its obligations as they become due, you may not receive the full Payment at Maturity of the securities.

The Estimated Initial Value of the securities, which was determined by us on the Pricing Date, is less than the price to public and may differ from the market value of the securities in the secondary market, if any.

The Estimated Initial Value of the securities was calculated by us on the Pricing Date and is less than the price to public. The Estimated Initial Value reflects our internal funding rate, which is the borrowing rate we pay to issue market-linked securities, as well as the mid-market value of the embedded derivatives in the securities. This internal funding rate is typically lower than the rate we would use when

PS-5

we issue conventional fixed or floating rate debt securities. As a result of the difference between our internal funding rate and the rate we would use when we issue conventional fixed or floating rate debt securities, the Estimated Initial Value of the securities may be lower if it were based on the levels at which our fixed or floating rate debt securities trade in the secondary market. In addition, if we were to use the rate we use for our conventional fixed or floating rate debt issuances, we would expect the economic terms of the securities to be more favorable to you. We determined the value of the embedded derivatives in the securities by reference to our or our affiliates’ internal pricing models. These pricing models consider certain assumptions and variables, which can include volatility and interest rates. Different pricing models and assumptions could provide valuations for the securities that are different from our Estimated Initial Value. These pricing models rely in part on certain forecasts about future events, which may prove to be incorrect. The Estimated Initial Value does not represent a minimum price at which we or any of our affiliates would be willing to purchase your securities in the secondary market (if any exists) at any time.

The price of your securities in the secondary market, if any, immediately after the Pricing Date will be less than the price to public.

The price to public takes into account certain costs. These costs, which will be used or retained by us or one of our affiliates, include the underwriting discount, our affiliates’ projected hedging profits (which may or may not be realized) for assuming risks inherent in hedging our obligations under the securities and the costs associated with structuring and hedging our obligations under the securities. If you were to sell your securities in the secondary market, if any, the price you would receive for your securities may be less than the price you paid for them because secondary market prices will not take into account these costs. The price of your securities in the secondary market, if any, at any time after issuance will vary based on many factors, including the level of the Reference Asset and changes in market conditions, and cannot be predicted with accuracy. The securities are not designed to be short-term trading instruments, and you should, therefore, be able and willing to hold the securities to maturity. Any sale of the securities prior to maturity could result in a loss to you.

If we were to repurchase your securities immediately after the Original Issue Date, the price you receive may be higher than the Estimated Initial Value of the securities.

Assuming that all relevant factors remain constant after the Original Issue Date, the price at which HSBC Securities (USA) Inc. may initially buy or sell the securities in the secondary market, if any, and the value that we may initially use for customer account statements, if we provide any customer account statements at all, may exceed the Estimated Initial Value on the Pricing Date for a temporary period expected to be approximately 12 months after the Original Issue Date. This temporary price difference may exist because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost of hedging our obligations under the securities and other costs in connection with the securities that we will no longer expect to incur over the term of the securities. We will make such discretionary election and determine this temporary reimbursement period on the basis of a number of factors, including the tenor of the securities and any agreement we may have with the distributors of the securities. The amount of our estimated costs which we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the Original Issue Date of the securities based on changes in market conditions and other factors that cannot be predicted.

The securities lack liquidity.

The securities will not be listed on any securities exchange. HSBC Securities (USA) Inc. is not required to offer to purchase the securities in the secondary market, if any exists. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the securities easily. Because other dealers are not likely to make a secondary market for the securities, the price at which you may be able to trade your securities is likely to depend on the price, if any, at which HSBC Securities (USA) Inc. is willing to buy the securities.

Potential conflicts of interest may exist.

HSBC and its affiliates play a variety of roles in connection with the issuance of the securities, including acting as calculation agent and hedging our obligations under the securities. In performing these duties, the economic interests of the calculation agent and other affiliates of ours are potentially adverse to your interests as an investor in the securities. We will not have any obligation to consider your interests as a holder of the securities in taking any action that might affect the value of your securities.

Uncertain tax treatment.

For a discussion of the U.S. federal income tax consequences of your investment in a security, please see the discussion under “U.S. Federal Income Tax Considerations” herein and the discussion under “U.S. Federal Income Tax Considerations” in the accompanying prospectus supplement.

PS-6

ILLUSTRATIVE EXAMPLES

The following table and examples are provided for illustrative purposes only and are hypothetical. They do not purport to be representative of every possible scenario concerning increases or decreases in the level of the Reference Asset relative to its Initial Level. We cannot predict the Final Level. The assumptions we have made in connection with the illustrations set forth below may not reflect actual events, and the hypothetical Initial Level used in the table and examples below is not the actual Initial Level. You should not take this illustration or these examples as an indication or assurance of the expected performance of the Reference Asset or the return on your securities. The Final Settlement Value may be less than the amount that you would have received from a conventional debt security with the same stated maturity, including such a security issued by HSBC. The numbers appearing in the table below and following examples have been rounded for ease of analysis.

The table below illustrates the Payment at Maturity on a $1,000 investment in the securities for a hypothetical range of Reference Returns from -100% to +100%. The following results are based solely on the assumptions outlined below. The “Hypothetical Return on the Securities” as used below is the number, expressed as a percentage, that results from comparing the Final Settlement Value per $1,000 Principal Amount to $1,000. The potential returns described here assume that your securities are held to maturity. You should consider carefully whether the securities are suitable to your investment goals. The following table and examples are based on the following terms:

4	Principal Amount:	$1,000

4	Hypothetical Initial Level:	2,000.00

4	Upside Participation Rate:	100%

4	Buffer Level:	-20%

The actual Initial Level is set forth on page PS-2 of this pricing supplement.

Hypothetical Final Level	Hypothetical Reference Return	Hypothetical Payment at Maturity	Hypothetical Return on the Securities
4,000.00	100.00%	$2,000.00	100.00%
3,600.00	80.00%	$1,800.00	80.00%
3,200.00	60.00%	$1,600.00	60.00%
2,800.00	40.00%	$1,400.00	40.00%
2,600.00	30.00%	$1,300.00	30.00%
2,400.00	20.00%	$1,200.00	20.00%
2,300.00	15.00%	$1,150.00	15.00%
2,200.00	10.00%	$1,100.00	10.00%
2,100.00	5.00%	$1,050.00	5.00%
2,040.00	2.00%	$1,020.00	2.00%
2,020.00	1.00%	$1,010.00	1.00%
2,000.00	0.00%	$1,000.00	0.00%
1,980.00	-1.00%	$1,000.00	0.00%
1,960.00	-2.00%	$1,000.00	0.00%
1,900.00	-5.00%	$1,000.00	0.00%
1,700.00	-15.00%	$1,000.00	0.00%
1,600.00	-20.00%	$1,000.00	0.00%
1,400.00	-30.00%	$900.00	-10.00%
1,200.00	-40.00%	$800.00	-20.00%
1,000.00	-50.00%	$700.00	-30.00%
800.00	-60.00%	$600.00	-40.00%
400.00	-80.00%	$400.00	-60.00%
0.00	-100.00%	$200.00	-80.00%

PS-7

The following examples indicate how the Final Settlement Value would be calculated with respect to a hypothetical $1,000 investment in the securities.

Example 1: The level of the Reference Asset increases from the Initial Level of 2,000.00 to a Final Level of 2,200.00.


Reference Return:	10.00%
Final Settlement Value:	$1,100.00

Because the Reference Return is positive, the Final Settlement Value would be $1,100.00 per $1,000 Principal Amount, calculated as follows:

$1,000 + ($1,000 × Reference Return × Upside Participation Rate)

= $1,000 + ($1,000 × 10.00% × 100%)

= $1,100.00

Example 1 shows that you will receive the return of your principal investment plus a return equal to the Reference Return multiplied by the Upside Participation Rate of 100% when the Reference Asset appreciates.

Example 2: The level of the Reference Asset decreases from the Initial Level of 2,000.00 to a Final Level of 1,900.00.


Reference Return:	-5.00%
Final Settlement Value:	$1,000.00

Because the Reference Return is less than zero but greater than the Buffer Level of -20%, the Final Settlement Value would be $1,000.00 per $1,000 Principal Amount (a zero return).

Example 3: The level of the Reference Asset decreases from the Initial Level of 2,000.00 to a Final Level of 1,000.00


Reference Return:	-50.00%
Final Settlement Value:	$700.00

Because the Reference Return is less than the Buffer Level of -20%, the Final Settlement Value would be $700.00 per $1,000 Principal Amount, calculated as follows:

$1,000 + [$1,000 × (Reference Return + 20%)]

= $1,000 + [$1,000 × (-50.00% +20%)]

= $700.00

Example 3 shows that you are exposed on a 1-to-1 basis to declines in the level of the Reference Asset beyond the Buffer Level of-20%. YOU MAY LOSE UP TO 80% OF THE PRINCIPAL AMOUNT OF YOUR SECURITIES.

PS-8

THE S&P 500^® Index (“SPX”)

Description of the SPX

The SPX is a capitalization-weighted index of 500 U.S. stocks. It is designed to measure performance of the broad domestic economy through changes in the aggregate market value of 500 stocks representing all major industries.

The top 5 industry groups by market capitalization as of January 26, 2016 were: Information Technology, Financials, Health Care, Consumer Discretionary and Consumer Staples.

For more information about the SPX, see “S&P 500^® Index” on page S-44 of the accompanying Equity Index Underlying Supplement.

Historical Performance of the SPX

The following graph sets forth the historical performance of the SPX based on the daily historical closing levels from January 1, 2008 through January 26, 2016. The closing level for the SPX on January 26, 2016 was 1,903.63. We obtained the closing levels below from the Bloomberg Professional^® service. We have not undertaken any independent review of, or made any due diligence inquiry with respect to, the information obtained from the Bloomberg Professional^® service.

The historical levels of the SPX should not be taken as an indication of future performance, and no assurance can be given as to the Official Closing Level of the SPX on the Final Valuation Date.

EVENTS OF DEFAULT AND ACCELERATION

If the securities have become immediately due and payable following an Event of Default (as defined in the accompanying prospectus) with respect to the securities, the calculation agent will determine the accelerated payment due and payable at maturity in the same general manner as described in “Payment at Maturity” in this pricing supplement. In that case, the scheduled trading day immediately preceding the date of acceleration will be used as the Final Valuation Date for purposes of determining the Reference Return, and the accelerated maturity date will be three business days after the accelerated Final Valuation Date. If a Market Disruption Event exists with respect to the Reference Asset on that scheduled trading day, then the accelerated Final Valuation Date for the Reference Asset will be postponed for up to five scheduled trading days (in the same manner used for postponing the originally scheduled Final Valuation Date). The accelerated maturity date will also be postponed by an equal number of business days.

If the securities have become immediately due and payable following an Event of Default, you will not be entitled to any additional payments with respect to the securities. For more information, see “Description of Debt Securities — Senior Debt Securities — Events of Default” in the accompanying prospectus.

SUPPLEMENTAL PLAN OF DISTRIBUTION (CONFLICTS OF INTEREST)

We have appointed HSBC Securities (USA) Inc., an affiliate of HSBC, as the agent for the sale of the securities. Pursuant to the terms of a distribution agreement, HSBC Securities (USA) Inc. will purchase the securities from HSBC at the price to public less the underwriting discount set forth on the cover page of this pricing supplement for distribution to other registered broker-dealers, or will offer the securities directly to investors. HSBC Securities (USA) Inc. will offer the securities at the price to public set forth on the cover page of this pricing supplement. HSBC USA Inc. or one of our affiliates may pay varying underwriting discounts of up to 3.75% and referral fees of up to 1.60% per $1,000 Principal Amount in connection with the distribution of the securities to other registered broker-dealers. In no case will the sum of the underwriting discounts and referral fees exceed 3.75% per $1,000 Principal Amount.

An affiliate of HSBC has paid or may pay in the future an amount to broker-dealers in connection with the costs of the continuing implementation of systems to support the securities.

In addition, HSBC Securities (USA) Inc. or another of its affiliates or agents may use this pricing supplement in market-making transactions after the initial sale of the securities, but is under no obligation to make a market in the securities and may discontinue any market-making activities at any time without notice.

See “Supplemental Plan of Distribution (Conflicts of Interest)” on page S-59 in the prospectus supplement.

PS-9

U.S. FEDERAL INCOME TAX CONSIDERATIONS

There is no direct legal authority as to the proper tax treatment of the securities, and therefore significant aspects of the tax treatment of the securities are uncertain as to both the timing and character of any inclusion in income in respect of the securities. Under one approach, a security should be treated as a pre-paid executory contract with respect to the Reference Asset. We intend to treat the securities consistent with this approach. Pursuant to the terms of the securities, you agree to treat the securities under this approach for all U.S. federal income tax purposes. Subject to the limitations described therein, and based on certain factual representations received from us, in the opinion of our special U.S. tax counsel, Morrison & Foerster LLP, it is reasonable to treat a security as a pre-paid executory contract with respect to the Reference Asset. Pursuant to this approach, we do not intend to report any income or gain with respect to the securities prior to their maturity or an earlier sale or exchange and we intend to treat any gain or loss upon maturity or an earlier sale or exchange as long-term capital gain or loss, provided that you have held the security for more than one year at such time for U.S. federal income tax purposes.

We will not attempt to ascertain whether any of the entities whose stock is included in, or owned by, the Reference Asset, as the case may be, would be treated as a passive foreign investment company (“PFIC”) or United States real property holding corporation (“USRPHC”), both as defined for U.S. federal income tax purposes. If one or more of the entities whose stock is included in, or owned by, the Reference Asset, as the case may be, were so treated, certain adverse U.S. federal income tax consequences might apply. You should refer to information filed with the SEC and other authorities by the entities whose stock is included in, or owned by, the Reference Asset, as the case may be, and consult your tax advisor regarding the possible consequences to you if one or more of the entities whose stock is included in, or owned by, the Reference Asset, as the case may be, is or becomes a PFIC or a USRPHC.

Under current law, while the matter is not entirely clear, individual non-U.S. holders, and entities whose property is potentially includible in those individuals’ gross estates for U.S. federal estate tax purposes (for example, a trust funded by such an individual and with respect to which the individual has retained certain interests or powers), should note that, absent an applicable treaty benefit, the securities are likely to be treated as U.S. situs property, subject to U.S. federal estate tax. These individuals and entities should consult their own tax advisors regarding the U.S. federal estate tax consequences of investing in the securities.

Recently finalized Treasury Regulations provide that withholding on “dividend equivalent” payments (as discussed in the accompanying prospectus supplement), if any, will not apply to securities issued before January 1, 2017. Additionally, the IRS has announced that withholding under the Foreign Account Tax Compliance Act (as discussed in the accompanying prospectus supplement) on payments of gross proceeds from a sale or redemption of the securities will only apply to payments made after December 31, 2018.

For a discussion of the U.S. federal income tax consequences of your investment in a security, please see the discussion under “U.S. Federal Income Tax Considerations” in the accompanying prospectus supplement.

VALIDITY OF THE SECURITIES

In the opinion of Morrison & Foerster LLP, as counsel to the Issuer, when this pricing supplement has been attached to, and duly notated on, the master note that represents the securities pursuant to the Senior Indenture referred to in the prospectus supplement dated March 5, 2015, and issued and paid for as contemplated herein, the securities offered by this pricing supplement will be valid, binding and enforceable obligations of the Issuer, entitled to the benefits of the Senior Indenture, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and equitable principles of general applicability (including, without limitation, concepts of good faith, fair dealing and the lack of bad faith). This opinion is given as of the date hereof and is limited to the laws of the State of New York, the Maryland General Corporation Law (including the statutory provisions, all applicable provisions of the Maryland Constitution and the reported judicial decisions interpreting the foregoing) and the federal laws of the United States of America. This opinion is subject to customary assumptions about the trustee’s authorization, execution and delivery of the Senior Indenture and the genuineness of signatures and to such counsel’s reliance on the Issuer and other sources as to certain factual matters, all as stated in the legal opinion dated March 5, 2015, which has been filed as Exhibit 5.3 to the Issuer’s registration statement on Form S-3 dated March 5, 2015.

PS-10


TABLE OF CONTENTS		You should only rely on the information contained in this pricing supplement, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this pricing supplement, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This pricing supplement, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus are not an offer to sell these securities, and these documents are not soliciting an offer to buy these securities, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this pricing supplement, the accompanying Equity Index Underlying Supplement, prospectus supplement and prospectus is correct on any date after their respective dates. HSBC USA Inc. $4,212,000 Buffered Uncapped Market Participation Securities Linked to the S&P 500^® Index January 26, 2016 PRICING SUPPLEMENT

Pricing Supplement
General	PS-3
Payment at Maturity	PS-3
Investor Suitability	PS-4
Risk Factors	PS-5
Illustrative Examples	PS-7
The S&P 500^® Index	PS-9
Events of Default and Acceleration	PS-9
Supplemental Plan of Distribution (Conflicts of Interest)	PS-9
U.S. Federal Income Tax Considerations	PS-10
Validity of the Securities	PS-10

Equity Index Underlying Supplement
Disclaimer	S-1
Risk Factors	S-2
The DAX^® Index	S-7
The Dow Jones Industrial Average^SM	S-9
The EURO STOXX 50^® Index	S-11
The FTSE^® 100 Index	S-13
The Hang Seng^® Index	S-14
The Hang Seng China Enterprises Index	S-16
The KOSPI 200 Index	S-19
The MSCI Indices	S-22
The NASDAQ 100 Index^®	S-26
The Nikkei 225 Index	S-30
The PHLX Housing Sector^SM Index	S-32
The Russell 2000^® Index	S-36
The S&P 100^® Index	S-40
The S&P 500^® Index	S-44
The S&P 500^® Low Volatility Index	S-47
The S&P BRIC 40 Index	S-50
The S&P MidCap 400^® Index	S-52
The TOPIX^® Index	S-55
Additional Terms of the Notes	S-57

Prospectus Supplement
Risk Factors	S-1
Pricing Supplement	S-8
Description of Notes	S-10
Use of Proceeds and Hedging	S-33
Certain ERISA Considerations	S-34
U.S. Federal Income Tax Considerations	S-37
Supplemental Plan of Distribution (Conflicts of Interest)	S-59

Prospectus
About this Prospectus	1
Risk Factors	2
Where You Can Find More Information	3
Special Note Regarding Forward-Looking Statements	4
HSBC USA Inc.	6
Use of Proceeds	7
Description of Debt Securities	8
Description of Preferred Stock	19
Description of Warrants	25
Description of Purchase Contracts	29
Description of Units	32
Book-Entry Procedures	35
Limitations on Issuances in Bearer Form	40
U.S. Federal Income Tax Considerations Relating to Debt Securities	40
Plan of Distribution (Conflicts of Interest)	49
Notice to Canadian Investors	52
Notice to EEA Investors	53
Notice to UK Investors	54
UK Financial Promotion	54
Certain ERISA Matters	55
Legal Opinions	57
Experts	58

424B2 2 v429884_424b2.pdf PRICING SUPPLEMENT begin 644 v429884_424b2.pdf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